Damaj, G., Joris, M., Chandesris, O., Hanssens, K., Soucie, E., Canioni, D., . . . Hermine, O. (2014). ASXL1 but Not TET2 Mutations Adversely Impact Overall Survival of Patients Suffering Systemic Mastocytosis with Associated Clonal Hematologic Non-Mast-Cell Diseases. Public Library of Science.
استشهاد بنمط شيكاغوDamaj, Gandhi, et al. ASXL1 but Not TET2 Mutations Adversely Impact Overall Survival of Patients Suffering Systemic Mastocytosis With Associated Clonal Hematologic Non-Mast-Cell Diseases. Public Library of Science, 2014.
MLA استشهادDamaj, Gandhi, et al. ASXL1 but Not TET2 Mutations Adversely Impact Overall Survival of Patients Suffering Systemic Mastocytosis With Associated Clonal Hematologic Non-Mast-Cell Diseases. Public Library of Science, 2014.